Novo Nordisk selected 2.4 mg once weekly for phase 3, and that is the dose used in REDEFINE 1 and REDEFINE 2
Integration of scRNA-seq with epigenomic approaches, such as single-cell sequencing assay for transposase-accessible chromatin (scATAC-seq) and DNA methylation profiling, allows identification of regulatory elements governing the expression of key genes, including those involved in survival, proliferation, and insulin secretion (Leenders et al., 2024
It assists in repairing damaged cells and maintaining overall cellular health, says Patel
Sharabati I, Qafesha RM, Hindawi MD, Amro S, Ayesh BM (2024) The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves orbitopathy: A systematic review and meta-analysis of randomised controlled trials
10.1016/S2214-109X(19)30327-4 Lancet Glob Health